3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia
2
Depression
2
Tuberous Sclerosis
1
Tourette Syndrome
1
Tic Disorders
1
Preleukemia
1
Neurodevelopmental Disorders
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Hot Flashes
1
Hematologic Diseases
1
Glioblastoma
1
Fragile X Syndrome
1
DiGeorge Syndrome
1
Cytopenia
1
Breast Neoplasms
1
Bone Marrow Diseases
1
Autistic Disorder
1
Autism Spectrum Disorder
1
Attention Deficit Disorder with Hyperactivity
1
Anxiety Disorders
1
Anemia
1
22q11 Deletion Syndrome
1
Interventions
Epoetin Alfa
10
Darbepoetin alfa
8
ferric carboxymaltose
7
fludarabine
4
Cyclophosphamide
4
Busulfan
4
Blood Transfusion
4
fludarabine phosphate
3
Filgrastim
3
Erythrocyte Transfusion
3
Cyclosporine
3
Biopsy
3
Antilymphocyte Serum
3
thymoglobulin
2
ruxolitinib
2
iron isomaltoside 1000
2
ferrous sulfate
2
ferrous fumarate
2
ferric gluconate
2
Vitamin B 12
2
Thiotepa
2
Therapeutics
2
Taxes
2
Surveys and Questionnaires
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Lenalidomide
2
Folic Acid
2
Ferric Oxide, Saccharated
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anemia
×
Sertraline
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled